ACG Wealth’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
Sell
-2,132
Closed -$349K 355
2017
Q4
$349K Sell
2,132
-319
-13% -$57.2K 0.05% 235
2017
Q3
$502K Sell
2,451
-644
-21% -$150K 0.09% 166
2017
Q2
$753K Sell
3,095
-215
-6% -$50.5K 0.12% 146
2017
Q1
$791K Buy
3,310
+385
+13% +$89.7K 0.14% 133
2016
Q4
$614K Sell
2,925
-5,214
-64% -$1.08M 0.13% 130
2016
Q3
$1.88M Sell
8,139
-254
-3% -$62.1K 0.4% 75
2016
Q2
$1.94M Buy
8,393
+82
+1% +$18.9K 0.43% 70
2016
Q1
$2.23M Buy
8,311
+2,793
+51% +$800K 0.5% 57
2015
Q4
$1.72M Buy
+5,518
New +$1.64M 0.39% 78

Other funds holding AGN

ACG Wealth's AGN Position: Q1 2018 in Review

ACG Wealth sold out of Allergan plc (AGN) in Q1 2018, closing a stake of 2,132 shares — an estimated $349K sold.

ACG Wealth first reported a position in AGN in Q4 2015 and held it in 9 quarters. The position peaked at $2.23M in Q1 2016. 1,022 funds tracked by Wall St. Rank hold AGN as of Q1 2018.

  • ACG Wealth reported no remaining Allergan plc position as of Q1 2018 after selling out during the quarter.
  • ACG Wealth sold 2,132 Allergan plc shares in Q1 2018, an estimated $349K.
  • ACG Wealth first reported a position in Allergan plc in Q4 2015 and held it in 9 quarters.
  • ACG Wealth's Allergan plc position peaked at $2.23M in Q1 2016.
  • 1,022 funds tracked by Wall St. Rank held Allergan plc as of Q1 2018.

Based on ACG Wealth's 13F filing for Q1 2018, filed 10 Apr 2018.